<html>
<head>PUBMED IDs for TSSC5</head>
<body bgcolor='#C5F0F2'><h1>TSSC5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9751628/'>Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5.</a> September 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10072438/'>Two novel genes in the center of the 11p15 imprinted domain escape genomic imprinting.</a> March 11  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10197590/'>Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction.</a> April 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10369881/'>Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.</a> June 17  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/12114541/'>Monoallelic expression and methylation of imprinted genes in human and mouse embryonic germ cell lineages.</a> July 13  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12613258/'>DHPLC-based method for DNA methylation analysis of differential methylated regions from imprinted genes.</a> March 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14595760/'>Loss of parental-specific methylation at the IGF2 locus in human hepatocellular carcinoma.</a> November 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16314844/'>Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.</a> November 30  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17686827/'>Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.</a> August 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17686824/'>Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.</a> August 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17686822/'>Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab.</a> August 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17686813/'>Bone morphogenetic protein-7 delays podocyte injury due to high glucose.</a> August 10  2007<br></body></html>
